Wave Life Sciences WVE Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's operating lease liabilities?
- Wave Life Sciences (WVE) reported operating lease liabilities of $7.39M in Q1 2026.
- How has Wave Life Sciences's operating lease liabilities changed year-over-year?
- Wave Life Sciences's operating lease liabilities decreased by 53.0% year-over-year, from $15.72M to $7.39M.
- What is the long-term trend for Wave Life Sciences's operating lease liabilities?
- Over 5 years (2020 to 2025), Wave Life Sciences's operating lease liabilities has grown at a -18.1% compound annual growth rate (CAGR), from $25.59M to $9.41M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.